Abel Hall LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428K | Buy |
6,205
+1,184
| +24% | +$81.7K | 0.2% | 105 |
|
|
2025
Q1 | $349K | Sell |
5,021
-992
| -16% | -$68.9K | 0.21% | 84 |
|
|
2024
Q4 | $517K | Buy |
6,013
+206
| +4% | +$17.7K | 0.33% | 43 |
|
|
2024
Q3 | $691K | Buy |
5,807
+162
| +3% | +$19.3K | 0.45% | 33 |
|
|
2024
Q2 | $806K | Buy |
5,645
+388
| +7% | +$55.4K | 0.57% | 30 |
|
|
2024
Q1 | $675K | Buy |
5,257
+212
| +4% | +$27.2K | 0.51% | 32 |
|
|
2023
Q4 | $522K | Buy |
+5,045
| New | +$522K | 0.45% | 35 |
|